Advertisement

Topics

Alpha Biologics Sdn Bhd Company Profile

03:41 EST 18th November 2017 | BioPortfolio

Alpha Biologics is a contract bio-manufacturing organisation offering process development and FDA/EMEA cGMP compliant services to the worldwide pharmaceutical and biotechnology industry. Initial process development is undertaken by Alpha's highly experienced team in Cambridge, UK, before being transferred to the 5,000 sq meter facility in Malaysia for final process technology transfer and manufacturing of biologics drugs for pre-clinical and clinical trials. The facility has been designed to produce primarily mammalian cell secreted proteins, including monoclonal antibodies and recombinant proteins. Managed by a team of specialists with significant cGMP manufacturing experience in the US, Europe and Asia that will ensure the highest standards of production and regulatory compliance. Future expansion plans in two stages are to add a 'fill/finish' operation and a microbial cell facility. We specialize in the production of mammalian cell secreted protein drugs, and we provide all of the necessary services required to develop and produce our clients' drugs in full compliance with U.S. and European cGMP guidelines. Our manufacturing base in Malaysia brings significant cost advantages to our customers due to the lower overhead costs compared with Europe or the U.S., whilst maintaining the highest standards of compliance. Our core team has extensive experience of designing, building and operating cGMP compliant facilities for biologic drugs in the U.S. and Europe. The core team comprises internationally trained and experienced staff from the world-wide biologics industry and academia. Our goal is to deliver drugs on time for clinical trials at a price that is affordable, thereby enabling our clients' to maintain strong drug development pipelines and realize maximum value from the investments in research and development.

Location

Plot 302, Taman Perindustrian Bukit MInyak,
Seberang Perai Tengah,
Penang
Penang
14100
Malaysia

Contact

Phone: +604 5081710
Fax: +604 5081702
Email: praveen.kumar@alphabiologics.com


News Articles [675 Associated News Articles listed on BioPortfolio]

X-ray Study Explains How Takinib Inhibits TNF-alpha

Takinib, a selective TAK1 inhibiting drug, has been shown to broaden the therapeutic efficacy of TNF-alpha (Tumor necrosis factor-alpha) inhibition...

Apic Bio seeded with $1mm

Gene therapy company Apic Bio Inc. spun off from the University of Massachusetts and was seeded with $1mm from the venture philanthropy arm of the Alpha-1 Foundation and private investor Ed Krapels, w...

Bruker Launches the ALPHA II, the Second Generation of the World’s Most Popular Compact FTIR System for Chemical Analysis, Applied Markets and Industrial Quality Control

Bruker launch the new ALPHA II, the latest generation of the ALPHA series of compact FTIR spectrometers. The ALPHA II features fully-automated test routines for validation regarding operati...

Penn Medicine neurosurgeon named alpha Omega Alpha Fellow in Leadership

(University of Pennsylvania School of Medicine) Timothy H. Lucas, II, MD, PhD, an assistant professor of Neurosurgery and director of the Translational Neuromodulation Lab in the Perelman School of Me...

Medical News Today: What are biologics for RA?

Biologics work by targeting the specific immune system cells that cause rheumatoid arthritis. Learn more about biologics in this article.

Alpha Tau Medical Secures Second Funding Round To Treat Solid Tumors With Alpha Radiation

  Life Sciences Jobs   ...

Apic Bio Launches To Advance First-In-Class Gene Therapy For Treatment Of Alpha-1 Antitrypsin Deficiency (Alpha 1)

  Life Sciences Jobs   ...

Drugs targeting the beta2-adrenoreceptor linked to Parkinson's disease

Lewy bodies - abnormal clumps of alpha-synuclein protein that accumulate in the brain - are a hallmark of Parkinson's disease (PD). Traditional drug development approaches for PD have focused on clear...

Drugs and Medications [159 Associated Drugs and Medications listed on BioPortfolio]

Isa knox x2d2 wrinkle serum [LG Household and Healthcare, Inc.]

Drug Facts

Doxazosin [Apotex Corp.]

DOXAZOSIN TABLETS, USP 1 mg, 2 mg, 4 mg and 8 mg

Cardura [Roerig]

CARDURA® (doxazosin mesylate) Tablets

Doxazosin mesylate [Golden State Medical Supply, Inc.]

DOXAZOSIN MESYLATE TABLETS, USP

Doxazosin mesylate [Major Pharmaceuticals]

DOXAZOSIN MESYLATE TABLETS

PubMed Articles [477 Associated PubMed Articles listed on BioPortfolio]

Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.

Biologic disease-modifying anti-rheumatic drugs (DMARDs: referred to as biologics) are effective in treating rheumatoid arthritis (RA), however there are few head-to-head comparison studies. Our syste...

Prolongation of biologic dosing intervals in patients with stable psoriasis: a feasibility study.

Biologics are usually licensed according to the "one dose fits all" principle. It is therefore suspected that a significant number of psoriasis patients are overtreated. However, evidence for successf...

Biosimilars: biologics that meet patients' needs and healthcare economics.

Biologics have revolutionized medical care, yet uniform access to these effective medicines remains difficult due to the increasing costs of healthcare. As patent exclusivity on the early biologics wa...

Cerebral PET glucose hypometabolism in subjects with mild cognitive impairment and higher EEG high-alpha/low-alpha frequency power ratio.

In Alzheimer's disease (AD) research, both 2-deoxy-2-((18)F)fluoro-D-glucose (FDG) positron emission tomography (PET) and electroencephalography (EEG) are reliable investigational modalities. The aim ...

The expanding field of biologics in the management of chronic urticaria.

Chronic urticaria (CU) is the occurrence of urticaria with or without angioedema for at least 6 weeks. Management has traditionally involved antihistamines as first-line therapy with various alternati...

Clinical Trials [887 Associated Clinical Trials listed on BioPortfolio]

Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

The patients included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health plan...

Positron Emission Tomography in Rheumatoid Arthritis With Adalimumab (PETRA)

Biologics are routinely used for the treatment of rheumatoid arthritis (RA). Adalimumab is a human monoclonal antibody that inhibit the Tumor Necrosis Factor alpha (TNF-alpha). Identificat...

Golimumab Safety and Surveillance Program Using the Ingenix NHI Database

The participants included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health ...

Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease

"RUN-CD" is an investigator initiated "Non interventional Trial" on biologics in Crohn´s Disease (CD) patients in Germany with a prospective documentation of effectiveness in induction an...

Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity

Rationale/hypothesis: Moderate-to-severe psoriasis can be treated with biologics. Objective To investigate whether the dose of biologics can be reduced in patients with psoriasis with sta...

Companies [319 Associated Companies listed on BioPortfolio]

Alpha-1 Foundation

The mission of the Alpha-1 Foundation is to provide the leadership and resources that will result in increased research, improved health, worldwide detection, and a cure for Alpha...

Siegfried Biologics GmbH

Siegfried Biologics, a business unit of Siegfried Ltd., consists of the corporate office located in Zofingen, Switzerland dealing with biotechnological development projects and biopharmaceutical contr...

The Alpha-1 Project

Mission statement: The Alpha-1 Project will work with patients, academia, pharmaceutical and biotech companies, and public health organizations in the relentless pursuit of cures ...

Alpha-1 Foundation and Foundation for Sarcoidosis Research

The mission of the Alpha-1 Foundation is to provide the leadership and resources that will result in increased research, improved health, worldwide detection, and a cure for Alpha...

Alpha-Stim

Alpha-Stim is an industry leader in cranial electrotherapy stimulation (CES) devices, providing treatment for anxiety, depression, insomnia and pain, without the side effects comm...

More Information about "Alpha Biologics Sdn Bhd" on BioPortfolio

We have published hundreds of Alpha Biologics Sdn Bhd news stories on BioPortfolio along with dozens of Alpha Biologics Sdn Bhd Clinical Trials and PubMed Articles about Alpha Biologics Sdn Bhd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alpha Biologics Sdn Bhd Companies in our database. You can also find out about relevant Alpha Biologics Sdn Bhd Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record